Singapore Regulator Seeks Faster Onboarding for Private Banking Clients Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Highs AI Stocks Enter Buy Zones UK Intelligence Chief Warns of Looming Geopolitical Threats Raising Investor Caution SP Global SPGI Mobility SpinOff Positions It as Dividend Stock for Retirement Portfolios OmniWorld to Shutter All Stores After 33 Years as Retail Landscape Shifts Synopsys Releases Financial Results for Second Quarter of Fiscal Year 2026 Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds Golden Entertainment GDEN Q4 2025 Earnings Steep Earnings Miss Amid Operational Challenges nVent Electric Q1 2026 Earnings Solid EPS Beat Despite Tepid Market Reaction SAN Q1 2026 Earnings EPS Surpasses Estimates by Over 31 Shares Dip Slightly DHCNI Q1 2026 Earnings Net Loss Misses Estimates Amid Challenging Environment DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction GDS Holdings Holds Steady Near 35 as Support and Resistance Levels Remain in Focus Westwood Holdings Group WHG Shows Modest Gains as Shares Test Resistance Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone EVGOW Warrants Trade at Penny Level as Downside Pressure Continues Ultragenyx RARE Edges Lower as Resistance Holds Support Levels Eyed Jim Cramer Advises Investors to Focus on AI Stocks Upside Potential Beyond Recent Rallies DSGN Q1 2026 Earnings Narrowerthanexpected loss drives positive sentiment Strata Critical Medical SRTA Surges 57 as Buyers Defend 582 Support Level Heritage Insurance Holdings Inc HRTG Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment DocGo Inc DCGO Q1 2026 Earnings EPS Misses as Revenue Data Remains Limited KR Q1 2026 Earnings EPS Beats Estimates Stock Declines 4 Despite Strong Core Performance NCLH Q1 2026 Earnings Strong EPS Beat of 58 Surprises Analysts Yet Stock Declines GLPG Q1 2026 Earnings Significant EPS Beat Driven by Cost Control and Operational Efficiency Woodward Inc WWD Q1 2026 Earnings EPS Beats Estimates by 782 as Stock Edges Lower Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD